oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Jaw Bone Samples From Bisphosphonate-Treated Patients: A Pilot Cohort Study
Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.;Orebro Univ Hosp, Dept Oral & Maxillofacial Surg, Orebro, Sweden..
Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.;BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden..
Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.;Sahlgrenska Univ Hosp Molndal, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden..
2015 (English)In: Clinical Implant Dentistry and Related Research, ISSN 1523-0899, E-ISSN 1708-8208, Vol. 17, E679-E691 p.Article in journal (Refereed) Published
Abstract [en]

Osteonecrosis of the jaw (ONJ) is a severe complication of bisphosphonate treatment. PurposeA detailed characterization of sampled peri-necrotic jawbone from bisphosphonate-treated patients was performed at tissue and cellular level (histological analyses and gene expression). Materials and MethodsAlveolar bone samples were collected from patients with (n=5) and without ONJ (n=5). Healthy patients served as controls (n=10). ResultsThe histological analysis demonstrated low to moderate inflammation, displaying areas of inflammatory infiltrate in the bone marrow. Multinuclear giant cells and osteoclasts were found in both groups. Markers of bone formation (alkaline phosphatase, Col1a1, and osteocalcin), bone resorption (receptor activator of NF-kappaB ligand [RANKL], osteoprotegerin [OPG], tartrate-resistant acid phosphatase, and cathepsin K), inflammation (tumor necrosis factor-alpha, interleukin [IL]-1, and IL-6), angiogenesis (vascular endothelial growth factor A), and apoptosis (Casp3, Casp8, p53, and Smac) were evaluated. Nonparametric statistical tests were used to identify differences between the groups. In patients with ONJ, the expression level of the proinflammatory marker IL-1 was strongly up-regulated compared with controls (p=.040). ConclusionsA down-regulated expression of Casp8 compared with controls was observed (p=.014) in patients treated with bisphosphonates. The RANKL/OPG ratios were similar in the three groups. The results indicate a need to further investigate the molecular mechanisms involved in the course of ONJ related to antiresorptive treatment.

Place, publisher, year, edition, pages
Wiley-Blackwell, 2015. Vol. 17, E679-E691 p.
Keyword [en]
bisphosphonates, gene expression, histology, inflammation, jawbone, ONJ
National Category
Dentistry
Identifiers
URN: urn:nbn:se:oru:diva-56333DOI: 10.1111/cid.12307ISI: 000362433400034PubMedID: 25916730OAI: oai:DiVA.org:oru-56333DiVA: diva2:1081661
Available from: 2017-03-14 Created: 2017-03-14 Last updated: 2017-03-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
In the same journal
Clinical Implant Dentistry and Related Research
Dentistry

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 2 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf